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Figure 1. Rainbow boxes displaying the 79 contraindications (26 distinct) of 8 drugs for erectile dysfunction. The drugs are shown in columns and the
contraindications in rectangular horizontal boxes (possibly with holes) covering the columns corresponding to the drugs sharing the contraindications.
Abstract—Overlapping set visualization is a well-known
problem in information visualization. This problem considers
elements and sets containing all or part of the elements, a
given element possibly belonging to more than one set. A
typical example is the properties of the 20 amino-acids. A
more complex application is the visual comparison of the
contraindications or the adverse effects of several similar drugs.
The knowledge involved is voluminous, each drug has many
contraindications and adverse effects, some of them are shared
with other drugs.
In this paper, we present rainbow boxes, a novel technique
for visualizing overlapping sets, and its application to the
properties of amino-acids and to the comparison of drug
properties. We also describe a user study comparing rainbow
boxes to tables and showing that the former allowed physicians
to find information significantly faster. We finally discuss the
limits and the perspectives of rainbow boxes.
Keywords-overlapping set visualization; knowledge visualiza-
tion; drug properties; user study;
I. INTRODUCTION
Drugs have many properties such as indications, con-
traindications, interactions, adverse effects, etc. These prop-
erties are listed in official textual documents called summary
of product characteristics (SPCs) and then gathered into drug
databases. The user interfaces of these databases allow a
physician to consult the properties of a single drug, but
not to compare several drugs with the same indication. The
VIIIP (Integrated Visualization of Information about Phar-
maceutical Innovation) research project aims at facilitating
the comparison of new drugs with the older similar drugs,
and proposing visual interface for this task. However, the
clear and concise presentation of the properties of a single
drug is already difficult, and thus the visual comparison of
the properties of 2-10 drugs is a real challenge.
The comparison of drug properties can be expressed as
an overlapping set visualization: drugs can be considered
as elements, and their properties (e.g. contraindications or
adverse effects) as sets including all drugs sharing the prop-
erty. Overlapping set visualization is a well-known field in
information visualization. Several elements are considered,
as well as sets containing all or part of these elements. The
sets are overlapping, i.e. a given element can belong to more
than one set. The objective of the visualization is to show
clearly which elements belong to a given set, which sets
include a given element but also to elicit new knowledge.
A typical and simple example of overlapping sets is the
“amino-acid properties” problem (see Figure 2). There are
20 amino-acids (e.g. Alanine, Proline) often abbreviated by
their 3-letter codes (Ala, Pro) or by their 1-letter code (A,
P). Several amino-acids share some physical or chemical
properties, such as their small size, the presence of an
aromatic cycle or a positive electric charge. A given amino-
acid can have zero, one or several properties (e.g. Histidine
has both an aromatic cycle and a positive charge). Thus the
amino-acids can be considered as elements and the properties
as overlapping sets of these elements. About 10 such prop-
erties are usually considered. In addition, properties are not
independent from each other: for example, it is obvious that
all tiny amino-acids are also small, and amino-acids with an
aromatic cycle cannot be small (because the aromatic cycle
is a big chemical structure). A good visualization is expected
to show clearly which are the properties of a given amino-
acid and which amino-acids share a given property, but
also to facilitate the discovery of new knowledge about the
amino-acids (e.g. Tyrosine and Tryptophan share the same
properties and thus they possibly exhibit similar biological
behavior) and their properties (e.g. the relation between the
small and aromatic properties detailed above).
In this paper, we present rainbow boxes, a novel tech-
nique for visualizing overlapping sets that we developed
for comparing drug properties. Rainbow boxes are well-
suited for knowledge visualization. They aim at presenting
relatively small datasets, typically involving 2-25 elements
and 5-100 sets, and at helping the discovery of classes of
similar elements or sets.
The rest of the paper is organized as follows. Section II
presents related works. Section III describes rainbow boxes
on the simple amino-acid example. Section IV describes
the use of rainbow boxes for comparing drug properties.
Section V gives implementation details. Section VI describes
a user study that has been conducted to evaluate rainbow
boxes in the drug comparison application. Finally, section
VII discusses the results and proposes perspectives.
Ile
Leu
Val
Met
His
Try
Tyr
Phe
Lys
Arg
Asp
Glu
Gln
Thr
Ala
CysGly
Ser
Pro
Asn
Small
Hydrophobic Polar
Aliphatic
Essential
Negative
Positive
Tiny
Aromatic
Figure 2. Venn diagram showing 9 properties of the 20 amino-acids.
II. RELATED WORKS
A. Overlapping set visualization
B. Alsakallah et al. recently reviewed the various meth-
ods proposed for overlapping set visualization [1]. They
distinguished 6 approaches: (1) Euler / Venn diagrams and
their variants represent an element by a dot and a set by
a closed curve containing all the dots that correspond to
the elements in the set (see amino-acid example Figure
2). These diagrams are easy to read but become more and
more complex when the number of sets increases above 4.
Additionally, it is difficult to generate automatically Euler /
Venn diagrams, although not impossible [2]. Variants use
lines instead of closed curves [3]. (2) Overlays rely on
a map, for elements that have a geographic location. (3)
Node-link diagrams represent the relation between elements
and sets as edges of a bipartite graph, like in Jigsaw [4].
(4) Matrix-based techniques represents sets and elements
in the rows and the columns of a two-dimensional matrix.
(5) Aggregation-based techniques aggregates the data, for
instance by computing frequencies, number of elements per
set or co-occurrences between sets, and then visualize the
aggregation. These techniques are interesting for very large
datasets. An example is Radial Sets [5]. (6) Scatterplot-
based techniques compute the distance between each pair of
elements, based on their set memberships, and then project
the elements on a two-dimensional plot.
B. Comparison of drug properties
Very few systems have been proposed for visualizing the
properties of several drugs together, and all of them relied
on simple matrices for displaying drug properties. Wroe
Figure 3. Rainbow boxes showing 10 properties of the 20 amino-acids.
et al. [6] proposed DOPAMINE, a spreadsheet-like matrix-
based tool, but this approach was limited and mostly aimed
toward reviewing and authoring drug properties. Iordatii
et al. [7] proposed a similar approach for comparing the
contraindications and the adverse effects of a new drug to
a reference drug. They used tabular matrices enriched by
colors. Drug Fact Boxes [8] offer some comparative drug
information, but limited to a few drugs and targeting patients
rather than physicians.
Duke et al. [9] designed an original system for viewing the
adverse effects of several drugs. The effects are “summed”
together; this system is interesting for analyzing the risk
associated with a drug order including several drugs, but
is not aimed at the comparison of similar drugs. Finally,
GraphSAW [10] is a graph-based tool for visualizing drug-
drug and drug-enzyme interactions and their relations with
drugs adverse effects.
III. RAINBOW BOXES
A. General principles
Rainbow boxes are a new technique for overlapping set
visualization, inspired by the matrix approaches. It aims at
visualizing relatively small datasets in detail and in particular
knowledge expressed as overlapping sets.
Figure 3 shows rainbow boxes displaying the amino-acid
properties. In rainbow boxes, the elements are displayed in
columns. Each set is displayed as a rectangular box covering
all the columns corresponding to the elements contained in
the set; the label of the set is shown inside the box. Sets
that are identical (i.e. they include the same elements) are
grouped in a single box. When necessary, holes are present
in a box (e.g. at the right of the small box in Figure 3). The
elements are ordered so as to limit the number of holes as
much as possible, using an algorithm described thereafter.
Wider boxes are placed at the bottom (global width is
considered, including holes). Then boxes are stacked at the
bottom like blocks in a “Tetris” game, i.e. several boxes can
be side by side as long as they do not occupy the same
columns.
By default, rainbow boxes do not use colors to add extra
information but rather to facilitate the reading and make
the visualization more appealing. Colors are attributed as
following: each element receives a different color, ranging
from red (left-most element) to violet (right-most element)
across the whole spectrum. The color of a box is the
mean (in RGB coordinates) of the colors of the elements
it contains. Consequently, a set including a single element
has the same, bright, color than the element, while bigger
sets with many elements tend to be grayish.
Nevertheless, colors can also be manually specified for
each (element, set) pair, in order to convey additional
information (we will see an example later on drugs adverse
effects). Boxes can also include hatches for representing
partial membership: for instance, in Figure 3, semi-essential
amino-acids (i.e. Tyr, Cys and Gly) are represented with
hatches in the essential box.
Rainbow boxes show set memberships of elements, but
also allow users to find new relations and similarities be-
tween elements or sets. For example, in Figure 3, set inclu-
sions are easy to see, e.g. all tiny amino-acids are also small
(since the small box covers all columns covered by the tiny
box) as well as set disjointness, e.g. aromatic amino-acids
are not small (the aromatic and small boxes have no common
column). Additionally, it is striking that essential amino-
acids are almost the same ones as hydrophobic amino-acids
(the two boxes spread over almost the same columns and
thus have similar colors).
Interactivity can be added to rainbow boxes by showing
popup bubbles with extra information when the mouse is
over column headers or boxes, and by allowing the user
to select two distinct elements to obtain a two-element
comparison.
B. Column ordering
For drawing optimal rainbow boxes with the smallest
possible number of holes, the column/element order must be
optimized. Testing all possible orders would be problematic,
because the number of possible orders is n! (i.e. factorial n)
where n is the number of elements, and thus it increases
greatly with n. The complexity of this problem is O(n!).
For the amino-acid example, there are 20! ≈ 2.43x1018
possible orders. To solve this problem in a satisfying time,
we propose a heuristic for computing a (near-to-)optimal
element order in a short time. It first generates a small set
Algorithm 1 The heuristic algorithm for finding candidate near-to-optimal element orders (candidate_orders). elements is a
set including all elements, and sets a set including all sets.
candidate_first_elements = { e0 for each element e0 in elements belonging to the highest number of set in sets }
orders_being_constructed = { tuple (e0) for each element e0 in candidate_first_elements }
candidate_orders = { } (empty set)
while orders_being_constructed 6= { }:
order = Get and remove one tuple from orders_being_constructed
remnant = elements \ order
possible_insertions = { (e, "beginning") for each e in remnant }
⋃
{ (e, "end") for each e in remnant }
for each couple (e, position) in possible_insertions with the highest insertion_score(e, position, order):
if position is "beginning": new_order = (e, order)
else if position is "end": new_order = (order, e)
if elements \ new_order = { }: Add new_order into candidate_orders
else: Add new_order into orders_being_constructed
function insertion_score(element, position, order):
if position is "beginning": neighbor = First element of order
else if position is "end": neighbor = Last element of order
score = 0
for each set x in sets, such as (element ∈ x) and (neighbor ∈ x): score = score + 2
for each set y in sets, such as (element /∈ y) and (order ⋂ y = { }): score = score + 1
return score
of candidate orders, and then tests all these candidate orders
for finding the best one (i.e. the one leading to the fewest
and shortest holes in the rainbow boxes). On the amino-acid
example, it tested 204 candidate orders.
The heuristic for generating candidate orders is shown in
Algorithm 1. Candidate order is constructed progressively,
starting with e0, the element belonging to the highest number
of sets, and thus the most “difficult” element to place (i.e.
the one that is the most susceptible to create holes, since
its column will contain the highest number of boxes). Then,
remnant elements are added one by one at the beginning
or the end of the order being constructed. The element to
insert and its position (at the beginning or at the end) is
determined by computing a score for each possible insertion
and choosing the insertion with the highest score. The score
takes into account (a) the number of sets that include both
the element to insert and the actual first (if inserting at the
beginning) or last (if inserting at the end) element in the
order being constructed, and (b) the number of sets that do
not include the element to insert and any element already
placed in the order being constructed. Part (a) favors the
insertion of an element that belongs to the same sets as its
future neighbor. Part (b) favors the insertion of an element
that does not belong to a set that is not yet present in
the order being constructed, i.e. it avoids beginning a new
box too early. Whenever several best choices are possible
for choosing e0 or the next insertion, all possibilities are
considered, thus producing several candidate orders.
IV. APPLICATION TO THE COMPARISON OF DRUGS
PROPERTIES
In this section, we describe the application of rainbow
boxes to the visualization of two categories of drug proper-
ties: contraindications and adverse effects (a third category,
interactions, has also been studied, but is very similar to
contraindications in terms of visualization and thus it is not
described here).
A. Comparison of contraindications
Figure 1 shows the contraindications of 8 drugs for
erectile dysfunction, using rainbow boxes. The basic rainbow
boxes described in section III have been enriched with:
(a) headers showing pharmaceutical classes of drugs, above
the column labels, e.g. “Prostaglandin E1” for Vitaros®,
(b) hatches for indicating unadvised situations, i.e. non-
absolute contraindications, for example severe renal failure
for Cialis®, (c) per-cell widgets, for providing additional
information on a given contraindication for a specific drug,
such as the “(non-controlled)” label for the “arterial hyper-
tension” contraindication of Cialis® or the colored bars in
the “Age” box, (d) VCM icons on the right of the boxes.
The VCM (Visualization of Concepts in Medicine) iconic
language [11] provides icons for representing the main
medical concepts, including patient conditions and disorders.
VCM includes a set of graphical primitives (colors, shapes
and pictograms) and a graphical grammar to combine them
for creating icons. VCM represent a clinical condition by
an icon with a color, a basic shape with zero, one or more
shape modifiers and a central pictogram. The color indicates
the temporal aspect of the icon: red for current states of the
patient, orange for risk of future states, and brown for past
states. The basic shape is a circle for physiological states or
a square for pathological states. The central pictogram indi-
cates the anatomico-functional location (e.g. endocrine sys-
tem) or the patient characteristic (e.g. pregnancy) involved;
special pictograms are available for a few specific disorders
Figure 4. Rainbow boxes displaying 116 adverse effects (56 distinct) of 8 drugs for erectile dysfunction. Custom colors are used for indicating seriousness
(red and orange hue) and frequency (saturation).
associated with a specific anatomico-functional location (e.g.
diabetes for endocrine system). Shapes modifiers can be
added to specify (a) a general pathological processes (e.g.
inflammation or tumor), and (b) a “transverse” anatomical
structure that can be present in many anatomico-functional
locations (e.g. blood vessels, which are present in most
organs).
Rainbow boxes in Figure 1 show the contraindications of
the 8 drugs, but also highlight the similarities between drugs
and in particular the similarities associated with the two
pharmaceutical classes. For instance, contraindication with
the predisposition to priapism is clearly a common property
of all prostaglandin E1 drugs.
Interactivity has also been added to this visualization:
by clicking on columns, the user can display a comparison
limited to two drugs (Figure 5), made of three parts: on the
top-left and top-right corners, contraindications specific to
the first and the second drugs, respectively, on the bottom,
contraindications shared by the two drugs. In each part, the
contraindications are also sorted by System Organ Class
(SOCs, e.g. cardiovascular system).
Figure 5. Comparison of the contraindications of Vitaros® with those of
Viagra®.
B. Comparison of adverse effects
Figure 4 shows an example of rainbow boxes comparing
adverse effects on the same eight drugs. Adverse effects are
more complex to visualize than contraindications, because
they are characterized by two additional attributes: serious-
ness and frequency. Seriousness is a boolean attribute and,
for frequency, 5 values are usually considered: very rare,
rare, infrequent, frequent and very frequent. For keeping a
manageable number of adverse effects, only serious and/or
frequent and very frequent effects have been considered.
The two attributes have been represented by the use of
custom colors on each cell. The hue indicates the serious-
ness (red: serious, orange: not serious) and the saturation
indicates the frequency (more saturated colors corresponding
to more frequent effects). Some boxes can have different
colors in various columns, e.g. the “Penile pain” box is
less saturated for Vitaros® because this effect occurs less
frequently than with the other prostaglandin E1 drugs.
Figure 4 allows users to easily find several statements,
such as: “Vitaros® has a lot of non-serious adverse effects”,
“Viagra® has many serious adverse effects, most of them
being shared with Cialis®”, or “Spedra® is the drug with
the fewest adverse effects”. Notice that the order of the
drugs differs between Figure 1 and 4, because drugs sharing
contraindications are not the same as drugs sharing adverse
effects (this is a known phenomenon is pharmacology).
V. IMPLEMENTATION
We implemented the system in Python 3, in two parts:
a module for generating rainbow boxes and another for
gathering drug properties. The first module produces HTML
pages with CSS and some JavaScript. The second allows
either to enter drug properties manually or to extract them
automatically from the French Thériaque drug database or
from the SPCs (for adverse effects only). The contraindica-
tions were coded in ICD-10 (International Classification of
Disease, 10th release) and adverse effects in MedDRA (Med-
ical Dictionary for Regulatory Activities). PyMedTermino
[12] was used for managing the two medical terminologies.
Drug properties were stored in a formal ontology [13] in
OWL/XML.
The full website (in French), aiming at compar-
ing new drugs to older similar drugs and featuring
rainbow boxes for 4 drug sets, can be consulted at
http://www.lesfleursdunormal.fr/static/viiip_proto/html ; the
first module, producing HTML rainbow boxes in Python, can
be downloaded at http://bitbucket.org/jibalamy/rainbowbox
as a Free Software (licensed under GNU LGPL v3), includ-
ing the examples shown in this paper.
VI. USER STUDY
A. Study design
Rainbow boxes were evaluated during a user study and
compared to tables. Tables were matrices with drugs in
columns and contraindications or adverse effects in rows
(Figure 6). Various colored symbols were used for rep-
resenting contraindications, unadvised conditions, and the
frequency and seriousness of adverse effects. In addition,
tables were dynamic and interactive: they allowed the user
to show the properties of a single drug, to compare the
properties of two drugs or to show all properties for all
drugs.
Figure 6. An excerpt of a dynamic table displaying adverse effects of
drugs for erectile dysfunction.
The user study followed a crossover experimental de-
sign. 3 drug sets were manually extracted, each drug set
included 2 comparisons (contraindications, adverse effects)
and each comparison was visualized using the 2 approaches
(dynamic table, rainbow boxes). This produced 12 (= 3x2x2)
documents. 12 single-choice questions were written and
validated by medical experts (2 questions for each com-
parison). Each question involved at least two drugs and its
answer was present in the corresponding comparison, e.g.
“Is Vitaros® better than Edex® for patients with a penile
implant? (Yes/No)” or “Which drug has the highest number
of serious cardiac adverse effects? (Vitaros®/Caverject®/ etc,
8 candidate responses)”.
Physicians were recruited and briefly introduced to dy-
namic tables and rainbow boxes (about 15 minutes). They
had to answer each question on a computer, using the
associated document, either dynamic table or rainbow boxes.
Physicians were divided in 2 groups; for a given comparison,
the first group has to respond to the first question with
dynamic table and to the second question with rainbow
boxes, while it was the contrary for the second group. When
the candidate responses were drug names, they were ordered
in the same order as in the visualization. The questions
were ordered so as the two questions based on the same
comparison were not next to each other, and two “warm-
up” questions were added at the beginning but their results
were not taken into account.
During the test, we measured the correctness of the
answers and the response time; after, we measured the
perceived usability through a SUS (System Usability Scale)
questionnaire [14]. Data were analyzed with R software
version 3.2.3. A general discussion was conducted with the
physicians after the test.
B. Results
22 physicians were recruited (12 males, 10 females,
mean of age: 54.6 years). They were interested in drug
comparisons and very enthusiastic. 9 physicians preferred
tables and 7 rainbow boxes (6 had no preference). The SUS
score was 72.0 for tables and 66.9 with rainbow boxes, this
difference is not significant (p-value 0.25, Wilcoxon test).
99 answers out of 132 (75%) were correct with tables ver-
sus 103 out of 132 (78%) with rainbow boxes, this difference
is not significant (p-value 0.66, Pearson’s Chi-squared test
with Yates’ continuity correction). Mean response time was
39.0 seconds with tables versus 29.7 seconds with rainbow
boxes, this difference is significant at risk α = 5% (p-value
0.011, Welch Two Sample t-test performed on log(response
time) for normalizing distributions).
During the discussion, physicians told us that they were
used to tables but that rainbow boxes were difficult to
understand at the beginning. They found that both would
be good at answering different types of questions in their
everyday life. They considered tables better for using during
consultation, when the physician has a particular patient in
mind. On the contrary, they found rainbow boxes better for
continuing education, when the physician needs a global
overview of the available drugs.
Figure 7. Rainbow boxes representing a random dataset of similar size
than the one in Figure 1.
VII. DISCUSSION
A. Rainbow boxes
B. Alsallaks et al. [1] described various tasks expected for
overlapping set visualization: 7 tasks related to elements, 14
related to sets and 5 related to element attributes. Rainbow
boxes can support many of these tasks, including basic
element tasks (A1-3), set tasks related to inclusion (B2-3),
exclusion (B4), intersection (B5-8) and similarity (B11).
Rainbow boxes were efficient for visualizing drug prop-
erties. However, drugs exhibit an important “class-effect”,
i.e. drugs tend to share common properties, determined
by their chemical structures, pharmacological mechanisms
or administration routes. On the contrary, when tested on
randomly generated data of similar size than the drug
applications (same number of elements, sets, and element-set
memberships), rainbow boxes lead to complex and hard-to-
read visualizations (Figure 7). As a consequence, rainbow
boxes are probably better-suited for visualizing elements for
which underlying classes of similar elements exist (these
classes can be already known or still to discover).
For optimizing elements ordering, several other methods
were tried, but the results were not as good as the proposed
heuristic. Principal component analysis (PCA) was tested:
each set was considered as a dimension and each element as
a point in that space. For a given dimension, the point coordi-
nate was set to 1 if the element belongs to the corresponding
set and to 0 otherwise. Then the first PCA’s resulting
dimension was used to order the elements. Tree building
algorithms were also tested (unweighted pair group method
with arithmetic mean, UPGMA, and neighbor-joining), and
then the tree was flattened. However, as the node’s children
are not ordered in trees, these methods yielded to poor
results. Finding the optimal node’s children ordering requires
to test all possible orders. For the amino-acid example, this
required to test 524 288 orders for UPGMA and 786 432
for neighbor-joining, which is less efficient than the heuristic
described here.
B. Application to the comparison of drug properties
Rainbow boxes were applied successfully to the com-
parison of drug properties. User study results showed that
physicians slightly preferred tables to rainbow boxes (SUS
score 72.0 vs 66.9) but they were able to find information
significantly faster with rainbow boxes. These results are not
necessarily contradictory: SUS measures perceived usability
but it is known that user satisfaction is not always correlated
with real effectiveness and efficiency [15]. The lower SUS
score for rainbow boxes might be explained by the fact that
physicians were already used to tables but were entirely new
to rainbow boxes. Some of the physicians also spontaneously
suggested that their age (mean: 54.6 years) might also ex-
plain that they had difficulties with new computer interfaces.
During the user study, rainbow boxes were compared to
dynamic tables. Tables were chosen as a reference because
it seemed the simplest and “natural” way for presenting drug
properties to the authors but also in the literature [6], [7].
Dynamic tables were an interactive improvement of plain
tables. A comparison with plain non-dynamic tables would
probably lead to a bigger difference in response time.
As suggested by physicians, rainbow boxes would be es-
pecially useful for education, e.g. for teaching the properties
of the various drugs and drug classes.
C. Perspectives
Rainbow boxes could be improved by taking into account
inclusion relations existing between sets. Some of these
relations can be already known (e.g. on the amino-acid
example, it is already known that the set of tiny amino-acids
is included in the set of small amino-acids) and could thus be
represented in the visualization, typically by incorporating
the tiny box inside the small box.
Many qualitative data and domains of knowledge can be
considered as overlapping sets. Thus rainbow boxes could
be applied to many other domains, especially for visualizing
knowledge about several items that are organized in classes
of similar items. Potential application domains include bioin-
formatics (e.g. for visualizing parts of Gene Ontology),
search engines, species classification and taxonomies, vi-
sualization of instances in an ontology, knowledge domain
visualization, etc.
VIII. CONCLUSION
In this article, we presented rainbow boxes, a novel
technique for visualizing overlapping sets, and an application
to the comparison of drug properties. We described a user
study showing that rainbow boxes allowed physicians to
find a given information significantly faster than with tables,
but also that they may need training before using this new
tool. Rainbow boxes are particularly efficient for visualizing
the similarities between known or yet-to-discover classes of
elements or sets, and they could potentially be applied to
many other domains.
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